 | • レポートコード：MRC2207A106 • 出版社/出版日：Transparency Market Research / 2022年5月 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トランスペアレンシー・マーケット・リサーチ社の本調査レポートでは、インドの動物医療市場市場について総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、動物種類別分析、治療種類別分析、流通チャネル別分析、競争状況などの内容をまとめております。なお、本書に掲載されている企業情報にはIDEXX Laboratories, Inc.、Virbac SA、Boehringer Ingelheim GmbH、Merial Ltd.、Ceva Sante Animale、Merck & Co. Inc.、Elanco Products Company、Bayer AGなどが含まれています。 |
India Animal Healthcare Market – Scope of Report
TMR’s report on the animal healthcare market in India studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the animal healthcare market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of animal healthcare market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the animal healthcare market in India.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the animal healthcare market in India.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the animal healthcare market in India. These serve as valuable tools for existing market players as well as for entities interested in participating in the animal healthcare market in India.
The report delves into the competitive landscape of the animal healthcare market. Key players operating in the animal healthcare market in India have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the animal healthcare market profiled in this report.
Research Methodology
The research methodology is a combination of exhaustive primary and secondary research to analyze the animal healthcare market.
Secondary Research
Secondary research included a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we referred to include, but are not limited to:
Company websites, presentations, annual reports, white papers, technical papers, product brochures
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
Veterinary Council of India
Indian Federation of Animal Health
Animal Welfare Board of India
Company Information
Statista
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of the research, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research.
We conducted primary interviews with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who took part in the process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts
Key opinion leaders specializing in the market with respect to different industry verticals
Primary participants included, but are not limited to:
Bayer AG
Elanco Products Company
Merck & Co., Inc.
Ceva Sante Animale
Virbac SA
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter
Market Estimation: Market size estimations involved an in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we used modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Population, inflation rates, and others
Industry Indicators: Production data, R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived by taking into account drivers, restraints/challenges, opportunities prevailing in the market, and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise consumption data are the other pivotal factors considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: India Animal Healthcare Market
4. Market Overview
4.1. Introduction
4.1.1. Animal Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. India Animal Healthcare Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Vendor and Distributor Analysis
5.2. Regulatory Scenario, by Region/Globally
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. India Animal Healthcare Market Analysis and Forecast, by Animal Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Animal Type, 2017–2031
6.3.1. Bovine
6.3.2. Porcine
6.3.3. Ovine
6.3.4. Poultry
6.4. Market Attractiveness Analysis, by Animal Type
7. India Animal Healthcare Market Analysis and Forecast, by Therapeutic Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Therapeutic Type, 2017–2031
7.3.1. Drugs
7.3.1.1. Analgesic
7.3.1.2. Antipyretic
7.3.1.3. Anti-inflammatory
7.3.1.4. Others
7.3.2. Vaccines
7.3.2.1. Live Attenuated
7.3.2.2. Inactivated Vaccine
7.3.2.3. Others
7.4. Market Attractiveness Analysis, by Therapeutic Type
8. India Animal Healthcare Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Veterinary Hospitals
8.3.2. Veterinary Clinics
8.3.3. Pharmacies
8.3.4. Others
8.4. Market Attractiveness Analysis, by Distribution Channel
9. India Animal Healthcare Market Analysis and Forecast, by Zone
9.1. Key Findings
9.2. Market Attractiveness Analysis, by Zone
10. India Animal Healthcare Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Animal Type, 2017–2031
10.2.1. Bovine
10.2.2. Porcine
10.2.3. Ovine
10.2.4. Poultry
10.3. Market Value Forecast, by Therapeutic Type, 2017–2031
10.3.1. Drugs
10.3.1.1. Analgesic
10.3.1.2. Antipyretic
10.3.1.3. Anti-inflammatory
10.3.1.4. Others
10.3.2. Vaccines
10.3.2.1. Live Attenuated
10.3.2.2. Inactivated Vaccine
10.3.2.3. Others
10.4. Market Value Forecast, by Distribution Channel, 2017–2031
10.4.1. Veterinary Hospitals
10.4.2. Veterinary Clinics
10.4.3. Pharmacies
10.4.4. Others
10.5. Market Value Forecast, by Zone, 2017–2031
10.6. Market Attractiveness Analysis
10.6.1. By Animal Type
10.6.2. By Therapeutic Type
10.6.3. By Distribution Channel
10.6.4. By Zone
11. Competition Landscape
11.1. Market Player – Competition Matrix (by tier and size of companies)
11.2. Company Profiles
11.2.1. Bayer AG
11.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.1.2. Product Portfolio
11.2.1.3. Financial Overview
11.2.1.4. SWOT Analysis
11.2.1.5. Strategic Overview
11.2.2. Elanco Products Company
11.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.2.2. Product Portfolio
11.2.2.3. Financial Overview
11.2.2.4. SWOT Analysis
11.2.2.5. Strategic Overview
11.2.3. Merck & Co. Inc.
11.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.3.2. Product Portfolio
11.2.3.3. Financial Overview
11.2.3.4. SWOT Analysis
11.2.3.5. Strategic Overview
11.2.4. Ceva Sante Animale
11.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.4.2. Product Portfolio
11.2.4.3. Financial Overview
11.2.4.4. SWOT Analysis
11.2.4.5. Strategic Overview
11.2.5. Merial Ltd.
11.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.5.2. Product Portfolio
11.2.5.3. Financial Overview
11.2.5.4. SWOT Analysis
11.2.5.5. Strategic Overview
11.2.6. Boehringer Ingelheim GmbH
11.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.6.2. Product Portfolio
11.2.6.3. Financial Overview
11.2.6.4. SWOT Analysis
11.2.6.5. Strategic Overview
11.2.7. Virbac SA
11.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.7.2. Product Portfolio
11.2.7.3. Financial Overview
11.2.7.4. SWOT Analysis
11.2.7.5. Strategic Overview
11.2.8. IDEXX Laboratories, Inc.
11.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.8.2. Product Portfolio
11.2.8.3. Financial Overview
11.2.8.4. SWOT Analysis
11.2.8.5. Strategic Overview
11.2.9. Other prominent players
11.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
11.2.9.2. Product Portfolio
11.2.9.3. Financial Overview
11.2.9.4. SWOT Analysis
11.2.9.5. Strategic Overview
Table 01: India Animal Healthcare Market Value (US$ Mn) Forecast, by Animal Type, 2017‒2031
Table 02: India Animal Healthcare Market Value (US$ Mn) Forecast, by Drugs, 2017‒2031
Table 03: India Animal Healthcare Market Value (US$ Mn) Forecast, by Vaccines, 2017‒2031
Table 04: India Animal Healthcare Market Value (US$ Mn) Forecast, by Therapeutic Type, 2017‒2031
Table 05: India Animal Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 06: India Animal Healthcare Market Value (US$ Mn) Forecast, by Zone, 2017‒2031